Algeria vs Vanuatu: Cause of death, by non-communicable diseases, ages 5-14, male
Algeria
39.5%
in 2021
Vanuatu
39.0%
in 2021
Algeria rank
77th
Vanuatu rank
79th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Algeria
- Vanuatu
How they compare
Algeria currently reports 39.5% against 39.0% in Vanuatu, a difference of 0.5%.
Across all 6 years both countries report, Algeria has been ahead every year.
Algeria ranks 77th and Vanuatu ranks 79th of 185 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.6% | 36.0% | 1.6% | Algeria |
| 2010s | 42.6% | 38.0% | 4.6% | Algeria |
| 2020s | 41.2% | 39.4% | 1.8% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Algeria or Vanuatu?
- Algeria, at 39.5% against 39.0% in Vanuatu as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Algeria and Vanuatu?
- 0.5%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Vanuatu?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Vanuatu rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Algeria ranks 77th and Vanuatu ranks 79th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.